Information about SaveRxCanada.to
List of countries where we can ship Canmab:
Latest news releases on Canmab:
Contact Us. To view location map click here Corporate Headquarters 20th KM, Hosur Road, Electronic City, Bangalore, India - 560 100 CIN:L24234KA1978PLC003417
We have seen the equity markets touch a new high this year. Here are 5 multi-bagger stocks for the next 5 years which can give you substantial returns.
About Us Biocon is Asia's premier biopharmaceutical company that is driven by the vision to make a difference to global healthcare through improved access to high quality, life-saving biotherapeutics by making them affordable for patients across the world.
Big Molecule Watch will be posting updates and analyses on regulatory issues, litigation, legislation, and other news in the ever-developing world of biosimilars.
Forward-Looking Statements: Mylan This press release includes statements that constitute "forward-looking statements," including with regard to: approval of Semglee; that the European Commission decision on the approval is expected in April; and that we have an important role to play to help increase access to high-quality, more affordable ...
History. Biocon was founded in 1978 with ₹ 10,000 (US$150) as the initial capital, failing to find any financial institution for investment. The operations began out of the garage of a rented house with two employees.
U.S. FDA Approves Mylan and Biocon's Fulphila™ (pegfilgrastim-jmdb), the First Biosimilar to Neulasta®
1. Introduction. Over the past twenty years, therapeutic antibodies have rapidly become the leading product within the biopharmaceutical market.